אודות פרק זה
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Mark Rutledge, President and CEO of World Precision Instruments.
Mark discusses how evolving research needs are reshaping the tools and technologies used in preclinical science. The conversation explores the growing importance of more standardized and physiologically relevant in vitro models, including organ-on-chip applications, as researchers look for better ways to generate meaningful data earlier in development.
Mark also shares perspective from his leadership experience across diagnostics, life sciences tools, and commercial organizations. He discusses how World Precision Instruments evaluates where to innovate, the role of customer insight in product development, and the challenges of leading an established scientific instrumentation company through changing research and market expectations.
This episode was streamed live on YouTube on September 28, 2026. Learn more at genecoda.com.
